In the wake of a transformative year for the global insurance sector, the intersection of artificial intelligence and venture capital has sparked what many are calling a “golden age” for technology. With global InsurTech funding rebounding to $5.1 billion in 2025—a nearly 20% increase after years of stagnation—the industry is witnessing a profound shift in how capital is deployed and how risk is managed. This resurgence is not merely a financial correction; it is a fundamental realignment driven by massive infrastructure investments and a strategic pivot toward AI-centric business models that promise to redefine the insurance value chain.
The following discussion explores the nuances of this recovery, examining the dominance of the U.S. market, the rise of B2B software solutions, and the evolving role of reinsurers in the startup ecosystem. From the “mega-rounds” fueling Property and Casualty innovation to the specialized developments in Life, Accident, and Health, this interview provides a comprehensive look at the trends shaping the future of insurance technology.
Big tech companies recently invested over $1 trillion into data centers and AI infrastructure. How does this massive foundational build-out directly impact the operational costs for insurance carriers, and what specific technical hurdles remain when integrating these advanced computing tools into legacy policy systems?
The trillion-dollar investment into the physical architecture of AI—the chips, data centers, and storage—serves as the necessary “plumbing” that makes advanced insurance applications possible. For carriers, this massive build-out creates a deflationary pressure on the cost of raw computing power, effectively lowering the barrier to entry for processing massive datasets that were previously too expensive to touch. However, the emotional and technical reality on the ground is far more complex; many legacy systems were built decades before “real-time data” was even a concept. The primary hurdle isn’t just the age of the code, but the siloed nature of the data, which makes it incredibly difficult to pipe these sophisticated AI tools into 30-year-old policy administration systems without significant risk of operational friction. We see insurers caught in a dual state of optimism and unease, knowing that while the infrastructure exists to revolutionize their efficiency, the “last mile” of integration requires a delicate, often costly, structural overhaul.
Global InsurTech funding recently rebounded to $5.1 billion, with roughly two-thirds of that capital flowing specifically toward AI-focused firms. Why are investors prioritizing AI over traditional tech-enabled models, and what metrics should carriers use to distinguish genuine innovation from speculative marketing hype?
The pivot toward AI is driven by a desire for durable tech models that offer more than just a digital “wrapper” around traditional processes. In 2025, we saw AI-focused InsurTechs capture $3.35 billion across 227 deals because investors are chasing the promise of exponential efficiency gains rather than incremental improvements. To cut through the noise, carriers should look beyond the “AI” label—which nearly 78% of Q4 2025 funding recipients claimed—and focus on metrics like model accuracy, reduction in claims cycle times, and the ability to integrate with existing workflows without manual intervention. It is vital to separate a product’s “science-fiction” promises from its actual ability to drive a 14% increase in average deal size, which suggests that the market is rewarding companies that demonstrate tangible, scalable utility rather than just clever marketing.
There is a notable market shift toward B2B software-first models rather than tech-enabled brokers or MGAs. What are the long-term trade-offs of this transition for the insurance value chain, and how can incumbent firms effectively pivot their internal structures to adopt these standalone technology solutions?
In 2025, the share of P&C deals going to B2B InsurTechs rose to 58%, a 12-percentage-point increase from the previous boom, while the share for brokers and MGAs fell to record lows. This shift suggests that the industry is moving away from competing on distribution and toward competing on the quality of the underlying technology stack. The trade-off is that while software-first models provide deeper efficiency and better underwriting tools, they require incumbents to transform from “risk aggregators” into “tech-savvy operators.” To pivot effectively, incumbent firms must move away from seeing technology as an outsourced utility and instead integrate it into the core of their strategy, recognizing that in today’s landscape, every insurer must essentially become a technology business to survive.
The United States now captures over 55% of global InsurTech deals, with Silicon Valley nearly doubling its activity share. How does this geographic concentration affect the development of products for international markets, and what steps can non-U.S. insurers take to remain competitive in this tech-heavy landscape?
The concentration of 55.74% of all deals in the U.S. creates a gravity well that naturally prioritizes products designed for the American regulatory and consumer environment. Silicon Valley alone saw its share jump to over 16%, which risks leaving international markets like France, Germany, and India—all of which saw declines in deal share—in a position where they must adapt U.S.-centric tools to their local needs. For non-U.S. insurers to remain competitive, they must lean into local partnerships and regional innovation hubs, much like the 162 tech investments made by (re)insurers globally in 2025. By fostering domestic InsurTech ecosystems and focusing on region-specific challenges like fragmented European regulations or emerging market distribution, they can create defensible moats that Silicon Valley’s general-purpose AI might overlook.
Reinsurers are increasingly making direct private technology investments at record-high levels. What strategic risks do these carriers face when acting as venture capitalists, and how should they structure these deals to ensure they drive tangible improvements in underwriting and claims processing?
When (re)insurers complete 162 tech investments in a single year, they are signaling a move from passive observation to active participation, but this carries the risk of “innovation theater” where capital is deployed without a clear path to integration. The danger lies in high stock-market valuations running ahead of actual revenue generation, which can lead to significant price corrections when financials eventually surface. To mitigate this, (re)insurers should structure deals with a heavy emphasis on “proof of concept” milestones that are tied directly to operational KPIs, such as improving the accuracy of catastrophe modeling or automating 20% of routine claims. By behaving less like traditional VCs and more like strategic partners, they can ensure that their capital doesn’t just fuel a startup’s growth, but actually hardens their own internal technological capabilities.
While Property and Casualty funding surged, the Life, Accident, and Health sector saw a slight funding dip even as AI became more central to its strategy. How is AI specifically transforming product development in the health space, and what efficiency gains are most critical for long-term competitiveness?
Despite a 4.6% dip in funding to $1.59 billion, the LAH sector is undergoing a profound internal transformation where AI is used to sharpen risk assessment and personalize product development. In this space, 64% of deals in 2025 were directed at B2B software solutions, highlighting a focus on the backend “engine” of insurance rather than the frontend sales. The most critical efficiency gains are found in the automation of medical underwriting and the use of predictive analytics to manage long-term health risks, which helps carriers remain competitive in a landscape of rising medical costs. AI allows for a more granular understanding of the policyholder, moving the sector away from broad actuarial pools and toward individualized risk pricing that was previously impossible.
Total funding for early-stage InsurTechs recently fell by about 9%, yet average deal sizes for these younger firms actually increased. What does this indicate about the current risk appetite of investors, and what practical steps should founders take to secure capital in such a selective environment?
The fall in total early-stage funding to $1.11 billion, paired with a 12.1% increase in average round size to $6.6 million, indicates a “flight to quality” where investors are placing larger bets on fewer, more proven teams. This suggests a cautious but concentrated risk appetite; investors are no longer spraying capital across the board but are instead looking for startups that can demonstrate a clear path to profitability and high technical defensibility. Founders looking to secure capital in this environment must move beyond “AI hype” and present concrete data on their product-market fit and their ability to integrate into the legacy systems of incumbent carriers. Practicality is now the highest currency—investors want to see that a founder understands the “boring” parts of insurance, like regulatory compliance and claims handling, just as well as they understand neural networks.
What is your forecast for InsurTech?
My forecast is that we are approaching a point where the term “InsurTech” will eventually become redundant because AI and advanced technology will be so deeply integrated into every facet of the industry that they will be synonymous with “insurance” itself. We will see a continued dominance of the B2B software-first model, which will force a massive consolidation among firms that cannot provide tangible efficiency gains beyond simple digital distribution. While the short-term market may experience “price corrections” as speculative AI valuations meet reality, the long-term trajectory is one where AI drives every digital interaction, redefining the transport of risk just as the internet redefined the transport of information over the last 25 years.